Skip to content

COntrolled MAp Trauma Brain Injury (COMAT Study)

Individualizing Mean Arterial Pressure of Head Trauma Injury Patients Using an Novel Automated System for Vasopressor Administration : a Randomized Controlled Trial

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03792581
Acronym
COMAT
Enrollment
0
Registered
2019-01-03
Start date
2019-04-01
Completion date
2019-12-30
Last updated
2019-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Closed-Loop Communication

Brief summary

The goal of this randomized controlled trial will be to show that the use of a novel automated system to guide vasopressor administration in head trauma injury patients will results in more time spent with a mean arterial pressure (MAP) within the predefined MAP compared to patients managed without any automated system (manually management)

Detailed description

In head trauma patients, the maintenance of MAP within a very narrow range is desired to avoid secondary ischemic diseases. However, the MAP needed to reach can vary over time based on intracranial pressure. Additionally, it is well know that the nurses in the Intensive care unit managed multiple patients simultaneously and cannot dedicate 100% of his-her time to adjust vasopressor infusion and/or fluid administration. Using a novel automated system can overcome this issue and may lead to more time in MAP target than the traditional management. All patients will have the same automated system for fluid administration using the EV1000 monitoring using the AFM mode ( Assisted fluid management). This system will recommend to the clinical when to administer a fluid bolus to optimize SV and SVV. So fluid administration will be standardized in both groups. The only difference will be the management of MAP. The goal will be to compare a treatment period of at least 3 hours during which the patient will be under continuous noradrenaline infusion. This treatment time should be within the first 48 hours of patient admission in the Intensive care unit.

Interventions

This system will recommend when patients need fluid or not and adjust vasopressor administration automatically

Sponsors

Bicetre Hospital
CollaboratorOTHER
University of California, Irvine
CollaboratorOTHER
University of California, Los Angeles
CollaboratorOTHER
Erasme University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Manual versus automated management of MAP

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Severe Head trauma Patients ( Glasgow score ≤8), intubated, ventilated and sedated

Exclusion criteria

* Glasgow score \>8 * Bilateral mydriasis at the initial management

Design outcomes

Primary

MeasureTime frameDescription
MEAN ARTERIAL PRESSURE (MAP)48 hours post-admission in the intensive caretime when MAP will be in the predefined range (+/- 5mmHg of the predefined MAP). This target can changed over the 48 hours of patient management due to increased intracranial pressure. This target is predefined by the clinician in charge of the patient and not involved in the study.

Secondary

MeasureTime frameDescription
Hypertension incidence48 hours post-admission in the intensive carepercentage time spent with MAP is above 5 mmHg of the predefined MAP target (hypotension) at 48 hours post admission
Pulsatility indexbaseline (admission to the intensive care unit)measure of pulsatility index using the Transcranial doppler ultrasound
Mean velocitybaseline (admission to the intensive care unit)measure of mean velocity using the Transcranial doppler ultrasound
diastolic velocitybaseline (admission to the intensive care unit)measure of diastolic velocity using the Transcranial doppler ultrasound
Diastolic velocity24 hours post-admission to the intensive care unitmeasure of diastolic velocity using the Transcranial doppler ultrasound
Hypotension incidence48 hours post-admission in the intensive carepercentage time spent with MAP is below 5 mmHg of the predefined MAP target (hypotension) at 48 hours post admission
Amount of vasopressor48 hours post-admission in the intensive careamount of vasopressor received during the first 48 hours post admission
Length of stay in the Intensive care unit30 days post-admission in the intensive carecomparison of the length of stay in the Intensive care unit between both groups
Mean arterial pressure (MAP)48 hours post-admission in the intensive careMAP over the first 48 hours postadmission in the intensive care
Stroke volume48 hours post-admission in the intensive carestroke volume over the first 48 hours postadmission in the intensive care
cardiac index48 hours post-admission in the intensive carecardiac index over the first 48 hours postadmission in the intensive care
Fluid received48 hours post-admission in the intensive carecomparison of amount of fluid received during the first 48 hours post admission

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026